Gold Nanoparticles Delivery Platinum Warheads to Tumors

Oct 29, 2009

(PhysOrg.com) -- Cisplatin is one of the most powerful and effective drugs for treating a wide variety of cancers, but serious side effects ultimately limit the drug's use and effectiveness. Now, however, researchers have developed a nanoparticulate formulation of cisplatin that may be able to eliminate or reduce platinum-associated toxicity while boosting cisplatin's tumor-killing activity.

Reporting its work in the , a team of investigators led by Stephen Lippard, of the Massachusetts Institute of Technology, and Chad Mirkin, of Northwestern University and principal investigator of the Northwestern Center for Cancer Nanotechnology Excellence, describes its development and characterization of nanoparticles as a delivery vehicle for a non-toxic form of platinum known as platinum(IV).

The are coated with short pieces of nucleic acid to which the investigators chemically attach platinum(IV). This construct can circulate safely through the blood stream and readily enter , which take up the nanoparticles and their payload by engulfing them in tiny pockets of cell membrane called endosomes. The acidic environment inside the endosome is such that platinum(IV) undergoes a chemical reaction that converts it into platinum(II), the highly toxic form of this element.

When administered to four different kinds of tumor cells, the nanoparticle-platinum(IV) construct was more toxic than an equivalent dose of cisplatin. But more importantly, the platinum(IV) compound itself, unattached to a nucleic acid-decorated gold nanoparticle, was unable to kill any of the treated . The investigators then showed that the nanoparticle-delivered platinum(IV) compound killed the treated tumor cells in the same way that cisplatin does.

More information: "Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads." An abstract of this paper is available at the journal's Web site.

Provided by National Cancer Institute (news : web)

Explore further: Gold nanorods target cancer cells

add to favorites email to friend print save as pdf

Related Stories

Study Details How Platinum Nanocages 'Cook' Cancer Cells

Aug 15, 2008

Platinum-based anticancer agents have a long history as proven therapeutic agents, but their toxicity and short lifetime in the body and the ability of tumors to develop resistance to these drugs limit the ultimate utility ...

Nanoscale 'Egg' Kills Tumor Cells with Platinum

Jan 22, 2007

Researchers at the Hong Kong University of Science and Technology have developed a nanoscale “egg” that could safely deliver platinum, a known anticancer agent, to tumor cells. Tests with this nanoscale egg, which has ...

Pack 'Em In -- Gold Nanoparticles Improve Gene Regulation

Feb 23, 2009

Investigators at Northwestern University have found that packing small interfering RNA (siRNA) molecules onto the surface of a gold nanoparticle can protect siRNAs from degradation and increase their ability to regulate genes ...

How Does the Antitumor Drug Get to the Cell Nucleus?

Oct 30, 2007

Platinum complexes such as the well-known cisplatin are powerful antitumor medications. They cross the cell membrane and reach the nucleus, where they attach to DNA and stop cell growth. But how does cisplatin get to the ...

Recommended for you

Gold nanorods target cancer cells

Dec 18, 2014

Using tiny gold nanorods, researchers at Swinburne University of Technology have demonstrated a potential breakthrough in cancer therapy.

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

theken101
not rated yet Oct 31, 2009
That should make health care affordable: gold nanoparticles delivering a platinum-based drug!
Rupyro
5 / 5 (1) Nov 01, 2009
Actually, many chemo treatments cost much more than gold or platinum, courtesy of drug companies...

If we can better target cancers, we can stop them while they are still small and manageble. Currently, no person in their right mind would opt for chemo if the tumor has not metastasized, but if this targeted chemo has fewer or no side effects, prophylactic treatment of benign cancers could be the future.

Not to mention that terminal illnesses like cancer use up over a third of our healthcare dollars.

This nanotech is the future of medicine and will significantly decrease the cost of healthcare.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.